A total of 258 individuals, including 114 individuals with a previous diagnosis of prostate cancer and 144 control men, were analyzed to determine the association of SRD5A2 gene polymorphisms with the pathological characteristics of the tumor and the risk of PC in the high altitude mestizo Ecuadorian population. Here, SRD5A2 is linked to prostate carcinoma.